Hyperthermic intraperitoneal perfusion chemotherapy and response evaluation in patients with gastric cancer and malignant ascites.

about

Hyperthermic intraperitoneal perfusion chemotherapy and response evaluation in patients with gastric cancer and malignant ascites.

Item

http://www.wikidata.org/entity/Q39151711

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Hyperthermic intraperitoneal p ...... cancer and malignant ascites.

@en

Hyperthermic intraperitoneal p ...... cancer and malignant ascites.

@nl

type

Item

label

Hyperthermic intraperitoneal p ...... cancer and malignant ascites.

@en

Hyperthermic intraperitoneal p ...... cancer and malignant ascites.

@nl

prefLabel

Hyperthermic intraperitoneal p ...... cancer and malignant ascites.

@en

Hyperthermic intraperitoneal p ...... cancer and malignant ascites.

@nl

P1476

Hyperthermic intraperitoneal p ...... cancer and malignant ascites.

@en

P2093

Bo Tian

http://www.w3.org/2001/XMLSchema#string

Changping Wu

http://www.w3.org/2001/XMLSchema#string

Jingting Jiang

http://www.w3.org/2001/XMLSchema#string

Jun Wu

http://www.w3.org/2001/XMLSchema#string

Mei Ji

http://www.w3.org/2001/XMLSchema#string

Ping Wu

http://www.w3.org/2001/XMLSchema#string

Xiaoxiao Xing

http://www.w3.org/2001/XMLSchema#string

Xuefeng Ni

http://www.w3.org/2001/XMLSchema#string

Yue Sun

http://www.w3.org/2001/XMLSchema#string

Zhenxing Jiang

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics, 2002

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

Toxicity and response criteria of the Eastern Cooperative Oncology Group

Using pharmacologic data to plan clinical treatments for patients with peritoneal surface malignancy.

Clinical pathway for the management of resectable gastric cancer with peritoneal seeding: best palliation with a ray of hope for cure.

Advanced gastric cancer with or without peritoneal carcinomatosis treated with hyperthermic intraperitoneal chemotherapy: a single western center experience.

Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer.

Hyperthermic intraperitoneal chemotherapy: Rationale and technique

Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group.

P304

1691-1696

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2017.6342

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-06-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28789396

http://www.w3.org/2001/XMLSchema#string

P932

5529911

http://www.w3.org/2001/XMLSchema#string